Evidence map›Paper›PMID 40584724›Full record

ArticleJTO clinical and research reports2025

The Landscape of

Jia Liao, Song Wu, Yi Min, Yiran Li, Yuanhang Nie, Quwen Chen, Zhiliang Mao, Qinglan Zong, Ning Gao, Ding Zhang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JTO clinical and research reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jia LiaoThe Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Guangdong, People's Republic of China.
Song WuDepartment of Thoracic Surgery, The Affiliated Jiangyin Hospital of Nantong University, Jiangsu, People's Republic of China.
Yi MinThe First Clinical Medical College, Guangdong Medical University, Guangdong, People's Republic of China.
Yiran LiDepartment of Respiratory and Critical Care Medicine, Foshan Second People's Hospital, Guangdong, People's Republic of China.
Yuanhang NieDepartment of Respiratory and Critical Care Medicine, Foshan Second People's Hospital, Guangdong, People's Republic of China.
Quwen ChenThe First Clinical Medical College, Guangdong Medical University, Guangdong, People's Republic of China.
Zhiliang MaoDepartment of Respiratory and Critical Care Medicine, Foshan Second People's Hospital, Guangdong, People's Republic of China.
Qinglan ZongDepartment of Medical Affairs, 3D Medicines Inc., Shanghai, People's Republic of China.
Ning GaoDepartment of Medical Affairs, 3D Medicines Inc., Shanghai, People's Republic of China.
Ding ZhangDepartment of Medical Affairs, 3D Medicines Inc., Shanghai, People's Republic of China.
Weiquan LiangDepartment of Respiratory and Critical Care Medicine, Foshan Second People's Hospital, Guangdong, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: A total of 11,330 tissue samples from 11,330 Chinese patients with lung cancer were included in the study to confirm the presence of Results: The highest detection rate of Conclusions: The mutations causing

Indexed as

Amplicon-based library constructionCapture-based library constructionLung cancerMETex14 skippingSecond generation sequencing

Identifiers

PMID40584724
PMCPMC12205784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.